These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2649340)

  • 21. Randomized, open-label, parallel-group evaluations of basal-bolus therapy versus insulin lispro premixed therapy in patients with type 2 diabetes mellitus failing to achieve control with starter insulin treatment and continuing oral antihyperglycemic drugs: a noninferiority intensification substudy of the DURABLE trial.
    Miser WF; Arakaki R; Jiang H; Scism-Bacon J; Anderson PW; Fahrbach JL
    Clin Ther; 2010 May; 32(5):896-908. PubMed ID: 20685497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment satisfaction in type 2 diabetes: a comparison between an inhaled insulin regimen and a subcutaneous insulin regimen.
    Cappelleri JC; Cefalu WT; Rosenstock J; Kourides IA; Gerber RA
    Clin Ther; 2002 Apr; 24(4):552-64. PubMed ID: 12017400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors.
    Ceriello A; Del Prato S; Bue-Valleskey J; Beattie S; Gates J; de la Peña A; Malone J
    J Diabetes Complications; 2007; 21(1):20-7. PubMed ID: 17189870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of lunch and bedtime NPH insulin plus mealtime insulin Lispro therapy with premeal regular insulin plus bedtime NPH insulin therapy in type 2 diabetes.
    Sargin H; Sargin M; Altuntaş Y; Sengül AM; Orbay E; Seber S; Uçak S; Yayla A
    Diabetes Res Clin Pract; 2003 Nov; 62(2):79-86. PubMed ID: 14581144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between insulin injection regimen and metabolic control in young Danish type 1 diabetic patients. The Danish Study Group of Diabetes in Childhood.
    Mortensen HB; Villumsen J; Vølund A; Petersen KE; Nerup J
    Diabet Med; 1992 Nov; 9(9):834-9. PubMed ID: 1473324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple insulin injection therapy using an insulin pen--who benefits? A clinical 3-year follow-up study of 100 type 1 and 51 type 2 diabetic patients.
    Rosengren A; Adlerberth A; Bresäter LE; Ehnberg S; Welin L
    Diabetes Res Clin Pract; 1993 Apr; 20(1):69-74. PubMed ID: 8344132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.
    Yki-Järvinen H; Dressler A; Ziemen M;
    Diabetes Care; 2000 Aug; 23(8):1130-6. PubMed ID: 10937510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Addition of biphasic insulin aspart 30 to rosiglitazone in type 2 diabetes mellitus that is poorly controlled with glibenclamide monotherapy.
    Raz I; Mouritzen U; Vaz J; Hershkovitz T; Wainstein J; Harman-Boehm I
    Clin Ther; 2003 Dec; 25(12):3109-23. PubMed ID: 14749149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.
    Chow CC; Tsang LW; Sorensen JP; Cockram CS
    Diabetes Care; 1995 Mar; 18(3):307-14. PubMed ID: 7555472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Twice daily insulin therapy in patients with type 2 diabetes and secondary failure to sulphonylureas.
    Wolffenbuttel BH; Weber RF; Weeks L; van Koetsveld PM; Verschoor L
    Diabetes Res; 1990 Feb; 13(2):79-84. PubMed ID: 2091874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control.
    DeVries JH; Snoek FJ; Kostense PJ; Masurel N; Heine RJ;
    Diabetes Care; 2002 Nov; 25(11):2074-80. PubMed ID: 12401759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(20):1-58. PubMed ID: 23074525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of breakfast and bedtime administration of insulin glargine in children and adolescents with Type 1 diabetes.
    Karagüzel G; Satilmiş A; Akçurin S; Bircan I
    Diabetes Res Clin Pract; 2006 Oct; 74(1):15-20. PubMed ID: 16621116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of intensive mixture therapy with basal insulin therapy in insulin-naïve patients with type 2 diabetes receiving oral antidiabetes agents.
    Jacober SJ; Scism-Bacon JL; Zagar AJ
    Diabetes Obes Metab; 2006 Jul; 8(4):448-55. PubMed ID: 16776752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of daily glucose excursion by continuous glucose monitoring between type 2 diabetic patients receiving preprandial insulin aspart or postprandial insulin glulisine.
    Ohta A; Arai K; Nishine A; Sada Y; Kato H; Fukuda H; Asai S; Nagai Y; Katabami T; Tanaka Y
    Endocr J; 2013; 60(2):173-7. PubMed ID: 23047542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Optimal timing of insulin detemir injection in patients with type 1 diabetes and poor metabolic control].
    Segovia Portolés R; Ferrer-García JC; Merino-Torres JF; Penalba MT; Albalat Galera R; Piñón-Selles F
    Endocrinol Nutr; 2010 Apr; 57(4):140-6. PubMed ID: 20347404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bedtime insulin injections: an alternative regimen.
    Hinde FR; Johnston DI
    Arch Dis Child; 1985 Apr; 60(4):311-5. PubMed ID: 3890764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus.
    Yki-Järvinen H; Kauppila M; Kujansuu E; Lahti J; Marjanen T; Niskanen L; Rajala S; Ryysy L; Salo S; Seppälä P
    N Engl J Med; 1992 Nov; 327(20):1426-33. PubMed ID: 1406860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of preprandial vs. postprandial insulin glulisine on weight and glycaemic control in patients initiating basal-bolus regimen for type 2 diabetes: a multicenter, randomized, parallel, open-label study (NCT00135096).
    Ratner R; Wynne A; Nakhle S; Brusco O; Vlajnic A; Rendell M
    Diabetes Obes Metab; 2011 Dec; 13(12):1142-8. PubMed ID: 21812890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved postprandial glycaemic control with insulin Aspart in type 2 diabetic patients treated with insulin.
    Rosenfalck AM; Thorsby P; Kjems L; Birkeland K; Dejgaard A; Hanssen KF; Madsbad S
    Acta Diabetol; 2000 Mar; 37(1):41-6. PubMed ID: 10928235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.